An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy

Summary

This trial is an open, national, multi-centre trial. The main objective of this trial is to assess the tolerability of the up-dosing phase of AVANZ® Cupressus arizonica by measurement of related Adverse Events.

Timeline

Start

2014-04

Primary completion

2014-11

Completion

2014-11

Drugs

Indications